Global Pharmaceutical Regulatory Affairs Summit
Connect with regulators and industry peers
X
Global Pharmaceutical Regulatory Affairs Summit
https://pharmaphorum.com/events/global-pharmaceutical-regulatory-affairs-summit/
emerging markets
MINT: opportunities in ‘frontier’ markets?
The prospects for pharma in the MINT emerging countries of Mexico, Indonesia, Nigeria and Turkey.
Six factors shaping healthcare in emerging markets
The factors shaping the healthcare landscape in emerging markets.
Novo aims for GLP-1 sales growth in China
Novo expects Victoza and semaglutide to gain momentum.
Pharma partners with African countries on chronic diseases
An innovative programme is being rolled out across Kenya.
Takeda preps for further acquisition
Japanese firm has set money aside for emerging markets M&A.
Going beyond CSR to reach ‘the two billion’
Impact of putting access to medicine at the core of pharma businesses.
Disrupting healthcare: 4 lessons from emerging markets
Ingenious low-cost solutions to healthcare problems in the developing world can inspire change in global healthcare.
GSK settles US bribery probe for $20m
Actions of Chinese subsidiaries violated US bribery laws, says SEC.
1 2
